Auditors question future of two tissue engineering firms
This article was originally published in Clinica
Executive Summary
Separate auditors have raised concerns over the ability of two rival tissue engineering companies to remain as going concerns. Both Organogenesis and Ortec International are taking steps to try to resolve their current situation.